Everything You Want to Know About PARP Inhibitors
PARP inhibitors have revolutionized ovarian cancer treatment and provided hope for so many patients. At the same time, a lot of questions often come up about their use: when should they be used? How long can they be taken for? PARP after PARP? Dr. Kathleen Moore, Director of the Oklahoma TSET Phase I Program at Stephenson Cancer Center, will provide an overview of PARP inhibitors and what the latest research shows. If you have questions about PARP inhibitors, this program is for you!